SOURCE: World Street Fundamentals

July 22, 2011 09:00 ET

Biosimilar Approvals Stimulates Entire Industry - Equity Research on Quest Diagnostics Incorporated and Laboratory Corp. of America Holdings

HONG KONG--(Marketwire - Jul 22, 2011) - Today, www.WorldStreetFundamentals.com released its industry report highlighting Quest Diagnostics Incorporated (NYSE: DGX) and Laboratory Corp. of America Holdings (NYSE: LH). Full fundamental and technical analysis is available at www.WorldStreetFundamentals.com/Reports.php.

This sector demonstrates renewed investor interest as revolutionary new therapies begin to find their way to the market, often boasting greater margins as a result. The FDA approved the first new drug in 50 years to treat auto-immune disorder lupus in March 2011. Our last update expected approval of new treatments for Hepatitis C virus around mid-year, and this has since come to pass right on target, Telaprevir was approved May 23, 2011 for treatment of chronic viral Hepatitis C. Such approvals are small realizations of the 2010 health care reform act authorizing the FDA to establish a regulatory pathway for approving "biosimilar" drugs. It is increasing production and shortening FDA approval times.

World Street Fundamentals has highlighted Quest Diagnostics Incorporated as a provider of diagnostic testing, information and services. It offers diagnostic testing services and products to patients, physicians, payers, and others. It offers the United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company owned patient service centers. It is a provider of clinical testing, including gene-based and esoteric testing, anatomic pathology services and testing for drugs-of-abuse, and the provider of risk assessment services for the life insurance industry. The entire report on Quest Diagnostics Incorporated (NYSE: DGX) is available here: www.WorldStreetFundamentals.com/ViewFullReport.245.php.

World Street has featured Laboratory Corp. of America Holdings (NYSE: LH) as an independent clinical laboratory company in the United States. The Company has a national network of 51 primary laboratories and over 1,700 patient service centers (PSCs) along with a network of branches and STAT laboratories, which are laboratories that have the ability to perform certain routine tests quickly and report the results to the physician immediately. The entire report on Laboratory Corp. of America Holdings (NYSE: LH) is available here: www.WorldStreetFundamentals.com/ViewFullReport.138.php.

About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets. Covering the top performers in the hottest sectors and providing clarity to investors around the world.

Contact Information